Insider transactions

EDGAR

SANARA MEDTECH INC.

Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, read from each filing’s XML. Codes and their wording are the SEC’s own.

A Form 4 is due within two business days of the transaction, so the most recent trades may not be filed yet.

Window: transactions dated on or after 2025-11-18.

Open-market purchases (code P)
0 transactions, — shares
Open-market sales (code S)
0 transactions, — shares

Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.

Showing 1–23 of 23

Insider transactions, newest first, as filed on SEC Forms 3, 4 and 5
DateReporting ownerCodeAcquired or disposedSharesPrice per share, as filedValue (derived)Shares owned afterDirect or indirectRule 10b5-1 boxNotesSource
2026-09-15 Filed 2026-09-16Yon Seth D Director · Officer: Chief Executive Officer
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)3,66135.11
128,537.71

Derived: shares × price per share. Exact value 128537.71.

105,885Direct (D) No
F1
  • F1 Represents shares of common stock of Sanara MedTech Inc. (the Issuer) withheld by the Issuer to satisfy tax withholding obligations in connection with the annual vesting of 9,521 shares of restricted stock previously granted to the reporting person. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.
Open filing 0001493152-26-042898 Read from the filing’s XML Dispute this row
2026-06-04 Filed 2026-06-05DeSutter Robert Andrew Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)5,5390—28,740Direct (D) No
F1
  • F1 Represents shares of restricted stock granted by Sanara MedTech Inc. (the Issuer) to the reporting person pursuant to the Sanara MedTech Inc. 2024 Omnibus Long-Term Incentive Plan. The restricted stock will vest on the earlier of (i) the date of the 2027 annual shareholder meeting or (ii) June 04, 2027, provided that the reporting person is providing certain services to the Issuer through such date.
Open filing 0001493152-26-027586 Read from the filing’s XML Dispute this row
2026-06-04 Filed 2026-06-05Ortwein Sara N Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)4,6160—25,415Direct (D) No
F1
  • F1 Represents shares of restricted stock granted by Sanara MedTech Inc. (the Issuer) to the reporting person pursuant to the Sanara MedTech Inc. 2024 Omnibus Long-Term Incentive Plan. The restricted stock will vest on the earlier of (i) the date of the 2027 annual shareholder meeting or (ii) June 04, 2027, provided that the reporting person is providing certain services to the Issuer through such date.
Open filing 0001493152-26-027591 Read from the filing’s XML Dispute this row
2026-06-04 Filed 2026-06-05TANZBERGER ERIC D Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)5,3080—22,966Direct (D) No
F1
  • F1 Represents shares of restricted stock granted by Sanara MedTech Inc. (the Issuer) to the reporting person pursuant to the Sanara MedTech Inc. 2024 Omnibus Long-Term Incentive Plan. The restricted stock will vest on the earlier of (i) the date of the 2027 annual shareholder meeting or (ii) June 04, 2027, provided that the reporting person is providing certain services to the Issuer through such date.
Open filing 0001493152-26-027593 Read from the filing’s XML Dispute this row
2026-06-04 Filed 2026-06-05Nixon Ronald T Director · 10% owner
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)4,1540—68,196Direct (D) No
F1
  • F1 Represents shares of restricted stock granted by Sanara MedTech Inc. (the Issuer) to the reporting person pursuant to the Sanara MedTech Inc. 2024 Omnibus Long-Term Incentive Plan. The restricted stock will vest on the earlier of (i) the date of the 2027 annual shareholder meeting or (ii) June 04, 2027, provided that the reporting person is providing certain services to the Issuer through such date.
Open filing 0001493152-26-027590 Read from the filing’s XML Dispute this row
2026-06-04 Filed 2026-06-05Major Eric D Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)4,8460—14,232Direct (D) No
F1
  • F1 Represents shares of restricted stock granted by Sanara MedTech Inc. (the Issuer) to the reporting person pursuant to the Sanara MedTech Inc. 2024 Omnibus Long-Term Incentive Plan. The restricted stock will vest on the earlier of (i) the date of the 2027 annual shareholder meeting or (ii) June 4, 2027, provided that the reporting person is providing certain services to the Issuer through such date.
Open filing 0001493152-26-027588 Read from the filing’s XML Dispute this row
2026-06-04 Filed 2026-06-05Mack Roszell III Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)5,3080—21,842Direct (D) No
F1
  • F1 Represents shares of restricted stock granted by Sanara MedTech Inc. (the Issuer) to the reporting person pursuant to the Sanara MedTech Inc. 2024 Omnibus Long-Term Incentive Plan. The restricted stock will vest on the earlier of (i) the date of the 2027 annual shareholder meeting or (ii) June 04, 2027, provided that the reporting person is providing certain services to the Issuer through such date.
Open filing 0001493152-26-027587 Read from the filing’s XML Dispute this row
2026-06-04 Filed 2026-06-05Salamone Ann Beal Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)4,1540—26,858Direct (D) No
F1
  • F1 Represents shares of restricted stock granted by Sanara MedTech Inc. (the Issuer) to the reporting person pursuant to the Sanara MedTech Inc. 2024 Omnibus Long-Term Incentive Plan. The restricted stock will vest on the earlier of (i) the date of the 2027 annual shareholder meeting or (ii) June 04, 2027, provided that the reporting person is providing certain services to the Issuer through such date.
Open filing 0001493152-26-027592 Read from the filing’s XML Dispute this row
2026-06-04 Filed 2026-06-05Myers Keith G Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)4,3850—9,325Direct (D) No
F1
  • F1 Represents shares of restricted stock granted by Sanara MedTech Inc. (the Issuer) to the reporting person pursuant to the Sanara MedTech Inc. 2024 Omnibus Long-Term Incentive Plan. The restricted stock will vest on the earlier of (i) the date of the 2027 annual shareholder meeting or (ii) June 04, 2027, provided that the reporting person is providing certain services to the Issuer through such date.
Open filing 0001493152-26-027589 Read from the filing’s XML Dispute this row
2026-05-15 Filed 2026-05-18Yon Seth D Director · Officer: Chief Executive Officer
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)3,85221.06
81,123.12

Derived: shares × price per share. Exact value 81123.12.

109,546Direct (D) No
F1
  • F1 Represents shares of common stock of Sanara MedTech Inc. (the Issuer) withheld by the Issuer to satisfy tax withholding obligations in connection with the annual vesting of 13,466 shares of restricted stock previously granted to the reporting person. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.
Open filing 0001493152-26-024170 Read from the filing’s XML Dispute this row
2026-04-15 Filed 2026-04-16Waldrop Jacob A. Officer: Chief Operating Officer
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)37820.01
7,563.78

Derived: shares × price per share. Exact value 7563.78.

24,377Direct (D) No
F1
  • F1 Represents shares of common stock of Sanara MedTech Inc. (the Issuer) withheld by the Issuer to satisfy tax withholding obligations in connection with the annual vesting of 1,551 shares of restricted stock previously granted to the reporting person. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.
Open filing 0001493152-26-017079 Read from the filing’s XML Dispute this row
2026-03-22 Filed 2026-05-05Mackey Ashley M Officer: Controller
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)2,8040—4,967Direct (D) No
F1, F2
  • F1 Represents shares of restricted stock granted by Sanara MedTech Inc. (the Issuer) to the reporting person pursuant to the Sanara MedTech Inc. 2024 Omnibus Long-Term Incentive Plan. The restricted stock will vest in three equal installments, with one-third of the shares vesting on March 22, 2027, 2028 and 2029, respectively, provided that the reporting person is employed by the Issuer through each such date.
  • F2 The original Form 4, filed on March 23, 2026, is being amended and restated in its entirety to reduce the number of shares of common stock of the Issuer reported as being beneficially owned by the reporting person. The original Form 4 mistakenly indicated that the reporting person held 5,067 shares of common stock, when in fact, as reported in this amendment, the reporting person held 4,967 shares of common stock following the reported transaction.
Open filing 0001493152-26-021296 Read from the filing’s XML Dispute this row
2026-03-22 Filed 2026-03-23Waldrop Jacob A. Officer: Chief Operating Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Disposed (D)13,9560—24,755Direct (D) No
F1
  • F1 Represents shares of restricted stock granted by Sanara MedTech Inc. (the Issuer) to the reporting person pursuant to the Sanara MedTech Inc. 2024 Omnibus Long-Term Incentive Plan. The restricted stock will vest in three equal installments, with one-third of the shares vesting on March 22, 2027, 2028 and 2029, respectively, provided that the reporting person is employed by the Issuer through each such date.
Open filing 0001493152-26-012181 Read from the filing’s XML Dispute this row
2026-03-22 Filed 2026-03-23Mackey Ashley M Officer: Controller
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Disposed (D)2,8040—5,067Direct (D) No
F1
  • F1 Represents shares of restricted stock granted by Sanara MedTech Inc. (the Issuer) to the reporting person pursuant to the Sanara MedTech Inc. 2024 Omnibus Long-Term Incentive Plan. The restricted stock will vest in three equal installments, with one-third of the shares vesting on March 22, 2027, 2028 and 2029, respectively, provided that the reporting person is employed by the Issuer through each such date.
Open filing 0001493152-26-012183 Read from the filing’s XML Dispute this row
2026-03-22 Filed 2026-03-23Taylor Elizabeth B Officer: Chief Financial Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Disposed (D)12,6870—17,632Direct (D) No
F1
  • F1 Represents shares of restricted stock granted by Sanara MedTech Inc. (the Issuer) to the reporting person pursuant to the Sanara MedTech Inc. 2024 Omnibus Long-Term Incentive Plan. The restricted stock will vest in three equal installments, with one-third of the shares vesting on March 22, 2027, 2028 and 2029, respectively, provided that the reporting person is employed by the Issuer through each such date.
Open filing 0001493152-26-012180 Read from the filing’s XML Dispute this row
2026-03-22 Filed 2026-03-23Yon Seth D Director · Officer: Chief Executive Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Disposed (D)25,4300—113,398Direct (D) No
F1
  • F1 Represents shares of restricted stock granted by Sanara MedTech Inc. (the Issuer) to the reporting person pursuant to the Sanara MedTech Inc. 2024 Omnibus Long-Term Incentive Plan. The restricted stock will vest in three equal installments, with one-third of the shares vesting on March 22, 2027, 2028 and 2029, respectively, provided that the reporting person is employed by the Issuer through each such date.
Open filing 0001493152-26-012179 Read from the filing’s XML Dispute this row
2026-03-07 Filed 2026-03-10Yon Seth D Director · Officer: Chief Executive Officer
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)59618.87
11,246.52

Derived: shares × price per share. Exact value 11246.52.

87,968Direct (D) No
F1
  • F1 Represents shares of common stock of Sanara MedTech Inc. (the Issuer) withheld by the Issuer to satisfy tax withholding obligations in connection with the annual vesting of 2,082 shares of restricted stock previously granted to the reporting person. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.
Open filing 0001493152-26-009530 Read from the filing’s XML Dispute this row
2026-03-01 Filed 2026-03-09Yon Seth D Director · Officer: Chief Executive Officer
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)41420.44
8,462.16

Derived: shares × price per share. Exact value 8462.16.

88,564Direct (D) No
F1, F2
  • F1 The original Form 4, filed on March 2, 2026, is being amended and restated in its entirety to reduce the number of shares of common stock of Sanara MedTech Inc. (the Issuer) withheld by the Issuer to satisfy tax withholding obligations in connection with the annual vesting of 1,446 shares of restricted stock previously granted to the Seth D. Yon (the Reporting Person). The original Form 4 mistakenly indicated that the Issuer withheld 491 shares of common stock, when in fact, as reported in this amendment, the Issuer withheld 414 shares of common stock.
  • F2 Represents shares of common stock of the Issuer withheld by the Issuer to satisfy tax withholding obligations in connection with the annual vesting of 1,446 shares of restricted stock previously granted to the Reporting Person. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.
Open filing 0001493152-26-009406 Read from the filing’s XML Dispute this row
2026-03-01 Filed 2026-03-02Yon Seth D Director · Officer: Chief Executive Officer
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)49120.44
10,036.04

Derived: shares × price per share. Exact value 10036.04.

88,487Direct (D) No
F1
  • F1 Represents shares of common stock of Sanara MedTech Inc. (the Issuer) withheld by the Issuer to satisfy tax withholding obligations in connection with the annual vesting of 1,446 shares of restricted stock previously granted to the reporting person. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.
Open filing 0001493152-26-008596 Read from the filing’s XML Dispute this row
2026-02-25 Filed 2026-02-27Waldrop Jacob A. Officer: Chief Operating Officer
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)71419.90
14,208.6

Derived: shares × price per share. Exact value 14208.60.

10,799Direct (D) No
F1
  • F1 Represents shares of common stock of Sanara MedTech Inc. (the Issuer) withheld by the Issuer to satisfy tax withholding obligations in connection with the annual vesting of 2,930 shares of restricted stock previously granted to the reporting person. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.
Open filing 0001493152-26-008339 Read from the filing’s XML Dispute this row
2026-02-25 Filed 2026-02-27Taylor Elizabeth B Officer: Chief Financial Officer
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)43719.90
8,696.3

Derived: shares × price per share. Exact value 8696.30.

4,945Direct (D) No
F1
  • F1 Represents shares of common stock of Sanara MedTech Inc. (the Issuer) withheld by the Issuer to satisfy tax withholding obligations in connection with the annual vesting of 1,794 shares of restricted stock previously granted to the reporting person. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.
Open filing 0001493152-26-008337 Read from the filing’s XML Dispute this row
2026-02-25 Filed 2026-02-27Yon Seth D Director · Officer: Chief Executive Officer
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)87319.90
17,372.7

Derived: shares × price per share. Exact value 17372.70.

88,978Direct (D) No
F1
  • F1 Represents shares of common stock of Sanara MedTech Inc. (the Issuer) withheld by the Issuer to satisfy tax withholding obligations in connection with the annual vesting of 3,049 shares of restricted stock previously granted to the reporting person. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.
Open filing 0001493152-26-008341 Read from the filing’s XML Dispute this row
2026-02-25 Filed 2026-02-27Mackey Ashley M Officer: Controller
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)14919.90
2,965.1

Derived: shares × price per share. Exact value 2965.10.

2,263Direct (D) No
F1
  • F1 Represents shares of common stock of Sanara MedTech Inc. (the Issuer) withheld by the Issuer to satisfy tax withholding obligations in connection with the annual vesting of 502 shares of restricted stock previously granted to the reporting person. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.
Open filing 0001493152-26-008335 Read from the filing’s XML Dispute this row

Institutional holders (Form 13F)

Quarter ending 2026-09-30: 8,793 filings read, the latest filed 2026-11-17. Prior quarter ending 2026-06-30: 9,164 filings read.

Showing 1–50 of 82

Institutional holders, largest position first, as filed
ManagerShares or principalValue as filedChange from the prior quarterSource
BlackRock, Inc. Partly reported under another manager429,517 SH15,093,227 dollarsHigher by 180,690 Prior quarter: 248,827Open filing 0002012383-26-003985 Filed 2026-11-13 Dispute this row
VANGUARD CAPITAL MANAGEMENT LLC 194,897 SH6,848,681 dollarsUnchanged Prior quarter: 194,897Open filing 0002100119-26-001711 Filed 2026-11-13 Dispute this row
Qube Research Technologies Ltd 176,318 SH6,195,815 dollarsHigher by 155,918 Prior quarter: 20,400Open filing 0001729829-26-000018 Filed 2026-11-13 Dispute this row
Transmarket Holdings LP 148,956 SH5,234,314 dollarsNot in the prior quarter’s filings read Open filing 0002134828-26-000005 Filed 2026-10-27 Dispute this row
ABC ARBITRAGE SA Partly reported under another manager140,894 SH4,951,015 dollarsNot in the prior quarter’s filings read Open filing 0000945621-26-001292 Filed 2026-10-23 Dispute this row
TORONTO DOMINION BANK 119,900 SH4,213,286 dollarsNot in the prior quarter’s filings read Open filing 0002052595-26-000123 Filed 2026-11-16 Dispute this row
RENAISSANCE TECHNOLOGIES LLC Partly reported under another manager114,100 SH4,009,474 dollarsHigher by 46,700 Prior quarter: 67,400Open filing 0001037389-26-000062 Filed 2026-11-12 Dispute this row
GARDNER LEWIS ASSET MANAGEMENT L P 112,461 SH3,951,880 dollarsNot in the prior quarter’s filings read Open filing 0000941560-26-000006 Filed 2026-11-13 Dispute this row
GEODE CAPITAL MANAGEMENT, LLC Partly reported under another manager105,346 SH3,702,914 dollarsHigher by 16,167 Prior quarter: 89,179Open filing 0001214717-26-000012 Filed 2026-11-06 Dispute this row
Alberta Investment Management Corp 102,400 SH3,598,336 dollarsNot in the prior quarter’s filings read Open filing 0001123292-26-001506 Filed 2026-11-09 Dispute this row
Polar Asset Management Partners Inc. 82,182 SH2,887,875 dollarsNot in the prior quarter’s filings read Open filing 0001326389-26-000099 Filed 2026-11-16 Dispute this row
STATE STREET CORP Partly reported under another manager68,241 SH2,397,989 dollarsHigher by 4,772 Prior quarter: 63,469Open filing 0000093751-26-000747 Filed 2026-11-12 Dispute this row
Sagefield Capital LP Partly reported under another manager65,782 SH2,311,580 dollarsNot in the prior quarter’s filings read Open filing 0001771179-26-000009 Filed 2026-11-16 Dispute this row
ExodusPoint Capital Management, LP 53,605 SH1,883,680 dollarsNot in the prior quarter’s filings read Open filing 0001736225-26-000013 Filed 2026-11-16 Dispute this row
MORGAN STANLEY Partly reported under another manager46,044 SH1,617,986 dollarsHigher by 22,416 Prior quarter: 23,628Open filing 0000895421-26-000309 Filed 2026-11-13 Dispute this row
D. E. Shaw Co., Inc. Partly reported under another manager45,741 SH1,607,339 dollarsHigher by 29,371 Prior quarter: 16,370Open filing 0001104659-26-128287 Filed 2026-11-16 Dispute this row
NORTHERN TRUST CORP Partly reported under another manager44,266 SH1,555,507 dollarsHigher by 7,825 Prior quarter: 36,441Open filing 0000073124-26-000067 Filed 2026-11-16 Dispute this row
MILLENNIUM MANAGEMENT LLC 36,990 SH1,299,829 dollarsNot in the prior quarter’s filings read Open filing 0001273087-26-000011 Filed 2026-11-16 Dispute this row
ROYAL BANK OF CANADA Partly reported under another manager35,143 SH1,235,000 dollarsLower by 226,847 Prior quarter: 261,990Open filing 0001140361-26-044123 Filed 2026-11-16 Dispute this row
VANGUARD PORTFOLIO MANAGEMENT LLC 33,852 SH1,189,559 dollarsHigher by 10,435 Prior quarter: 23,417Open filing 0002100121-26-001150 Filed 2026-11-13 Dispute this row
FMR LLC Partly reported under another manager29,616 SH1,040,706 dollarsHigher by 28,489 Prior quarter: 1,127Open filing 0000315066-26-002964 Filed 2026-11-10 Dispute this row
GOLDMAN SACHS GROUP INC Partly reported under another manager28,998 SH1,018,989 dollarsLower by 45,200 Prior quarter: 74,198Open filing 0000886982-26-000647 Filed 2026-11-16 Dispute this row
VANGUARD FIDUCIARY TRUST CO 28,899 SH1,015,511 dollarsHigher by 2,872 Prior quarter: 26,027Open filing 0000933478-26-000017 Filed 2026-11-13 Dispute this row
NATIXIS 28,839 SH1,012,249 dollarsNot in the prior quarter’s filings read Open filing 0001104659-26-123632 Filed 2026-11-06 Dispute this row
Russell Investments Group, Ltd. Partly reported under another manager26,285 SH923,674 dollarsHigher by 25,309 Prior quarter: 976Open filing 0001193125-26-451241 Filed 2026-11-06 Dispute this row
JANE STREET GROUP, LLC Partly reported under another manager26,222 SH921,441 dollarsLower by 24,584 Prior quarter: 50,806Open filing 0001595888-26-000162 Filed 2026-11-12 Dispute this row
CREDIT INDUSTRIEL ET COMMERCIAL Partly reported under another manager26,183 SH920,071 dollarsNot in the prior quarter’s filings read Open filing 0001274419-26-000014 Filed 2026-11-13 Dispute this row
AQR CAPITAL MANAGEMENT LLC Partly reported under another manager25,965 SH912,393 dollarsLower by 86,242 Prior quarter: 112,207Open filing 0001167557-26-000324 Filed 2026-11-16 Dispute this row
HILL ISLAND FINANCIAL LLC 24,291 SH853,586 dollarsNot in the prior quarter’s filings read Open filing 0001951757-26-001690 Filed 2026-10-20 Dispute this row
PRICE T ROWE ASSOCIATES INC /MD/ Partly reported under another manager20,214 SH711 dollarsHigher by 962 Prior quarter: 19,252Open filing 0000080255-26-000736 Filed 2026-11-16 Dispute this row
Rockefeller Capital Management L.P. Partly reported under another manager18,742 SH658,594 dollarsHigher by 4,349 Prior quarter: 14,393Open filing 0001739439-26-000009 Filed 2026-11-13 Dispute this row
Jump Financial, LLC Partly reported under another manager17,000 SH597,380 dollarsNot in the prior quarter’s filings read Open filing 0000905148-26-004786 Filed 2026-11-13 Dispute this row
Bank of New York Mellon Corp Partly reported under another manager16,061 SH564,383 dollarsNot in the prior quarter’s filings read Open filing 0001390777-26-000121 Filed 2026-11-05 Dispute this row
DIMENSIONAL FUND ADVISORS LP Partly reported under another manager15,748 SH553,359 dollarsHigher by 6,372 Prior quarter: 9,376Open filing 0000354204-26-001096 Filed 2026-11-04 Dispute this row
WATER ISLAND CAPITAL LLC 14,601 SH513,079 dollarsNot in the prior quarter’s filings read Open filing 0001222765-26-000016 Filed 2026-11-13 Dispute this row
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 13,473 SH473,441 dollarsHigher by 3,463 Prior quarter: 10,010Open filing 0000884546-26-000417 Filed 2026-11-16 Dispute this row
Carlson Capital, L.P. 13,300 SH467,362 dollarsNot in the prior quarter’s filings read Open filing 0001056973-26-000013 Filed 2026-11-09 Dispute this row
Nuveen, LLC Partly reported under another manager11,529 SH405,129 dollarsHigher by 428 Prior quarter: 11,101Open filing 0000930413-26-003284 Filed 2026-11-10 Dispute this row
Janney Montgomery Scott LLC Partly reported under another manager10,030 SH352 dollarsLower by 7,500 Prior quarter: 17,530Open filing 0001329948-26-000008 Filed 2026-11-12 Dispute this row
TWO SIGMA INVESTMENTS, LP 9,678 SH340,085 dollarsNot in the prior quarter’s filings read Open filing 0000899140-26-001341 Filed 2026-11-16 Dispute this row
CITIGROUP INC Partly reported under another manager8,687 SH305,261 dollarsHigher by 4,671 Prior quarter: 4,016Open filing 0000831001-26-000052 Filed 2026-11-04 Dispute this row
Mint Tower Capital Management B.V. Partly reported under another manager8,462 SH297 dollarsNot in the prior quarter’s filings read Open filing 0001666606-26-000008 Filed 2026-11-09 Dispute this row
AMERICAN CENTURY COMPANIES INC Partly reported under another manager7,411 SH260,423 dollarsNot in the prior quarter’s filings read Open filing 0000748054-26-000008 Filed 2026-11-12 Dispute this row
STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM Partly reported under another manager7,100 SH249,494 dollarsNot in the prior quarter’s filings read Open filing 0000938076-26-000015 Filed 2026-11-13 Dispute this row
BANK OF AMERICA CORP /DE/ Partly reported under another manager6,336 SH222,647 dollarsLower by 9,609 Prior quarter: 15,945Open filing 0000070858-26-000589 Filed 2026-11-16 Dispute this row
Wealthspire Advisors, LLC 6,109 SH214,671 dollarsNot in the prior quarter’s filings read Open filing 0001646247-26-000006 Filed 2026-11-13 Dispute this row
CANADA PENSION PLAN INVESTMENT BOARD 5,800 SH203,812 dollarsNot in the prior quarter’s filings read Open filing 0001104659-26-128255 Filed 2026-11-16 Dispute this row
RHUMBLINE ADVISERS 4,651 SH163,430 dollarsHigher by 2,101 Prior quarter: 2,550Open filing 0001115418-26-000015 Filed 2026-11-10 Dispute this row
UBS Group AG Partly reported under another manager4,635 SH162,874 dollarsHigher by 4,279 Prior quarter: 356Open filing 0001610520-26-000121 Filed 2026-11-10 Dispute this row
DEUTSCHE BANK AG\ Partly reported under another manager3,591 SH126,188 dollarsLower by 552 Prior quarter: 4,143Open filing 0000948046-26-000083 Filed 2026-11-06 Dispute this row
Managers in the prior quarter with no filing read for the latest

They may simply not have filed yet: absent from the latest quarter’s filings read is not the same as a position sold.

  • Stonebridge Wealth Management, LLC 129,452 SH
  • Squarepoint Ops LLC 53,811 SH
  • MARSHALL WACE, LLP 49,457 SH
  • CITADEL ADVISORS LLC 36,813 SH
  • JACOBS LEVY EQUITY MANAGEMENT, INC 31,644 SH
  • Walleye Capital LLC 30,465 SH
  • LOS ANGELES CAPITAL MANAGEMENT LLC 26,830 SH
  • Evernest Financial Advisors, LLC 25,700 SH
  • HSBC HOLDINGS PLC 23,254 SH
  • Baird Financial Group, Inc. 21,075 SH
  • Quadrature Capital Ltd 10,588 SH
  • SALEM INVESTMENT COUNSELORS INC 10,134 SH
  • Sixth Street Partners Management Company, L.P. 10,010 SH
  • Trexquant Investment LP 9,413 SH
  • HARBOUR INVESTMENTS, INC. 4,000 SH
  • NEW YORK STATE COMMON RETIREMENT FUND 2,433 SH
  • MERCER GLOBAL ADVISORS INC /ADV 1,972 SH
  • NewEdge Advisors, LLC 758 SH
  • FIDUCIARY FINANCIAL ADVISORS 612 SH
  • Integrated Wealth Concepts LLC 372 SH
  • Optiver Holding B.V. 6 SH
  • Covestor Ltd 2 SH
  • Wealth Enhancement Trust Services, Inc. 1 SH
  • JPL Wealth Management, LLC 1 SH
  • Clearstead Advisors, LLC 1 SH
  • Form 13F covers long positions in Section 13(f) securities only: no short positions and no securities outside that list.
  • A manager that has not yet filed for the latest quarter is absent, not at zero; filings are due up to 45 days after quarter end.
  • A change is the difference between two quarter-end snapshots, not a trade.
  • A position reported under another manager may also appear in that manager’s filing; rows are not added together.
  • Holdings the securities list cannot place with this company, or places ambiguously, are not shown.

Trades by members of Congress

Periodic transaction reports filed by U.S. House members that name this company’s stock. Dates and amounts are as filed.

No House member’s trade in this company is placed in the store. A trade not yet filed or not linked to a company is absent, not zero.

5% holders (Schedule 13D and 13G)

Schedules filed in the SEC’s structured format (late 2024 onward) are read here. Earlier schedules are free text and are not read.

5% holders, newest event first, as filed
HolderPercent of classShares heldEvent dateFormSource
THE GOLDMAN SACHS GROUP, INC. Common Stock, $0.001 Par Value5.0462,021.0009/30/2026 Filed 2026-11-09SCHEDULE 13GOpen filing 0000886982-26-000562 Dispute this row
GOLDMAN SACHS CO. LLC Common Stock, $0.001 Par Value5.0462,021.0009/30/2026 Filed 2026-11-09SCHEDULE 13GOpen filing 0000886982-26-000562 Dispute this row
Tall Pines Capital, LLC Common Stock, $0.001 par value0.00.0007/30/2026 Filed 2026-07-31SCHEDULE 13G/AAmendment 1Open filing 0001214659-26-009273 Dispute this row
Stonebridge Wealth Management, LLC Common Stock, $0.001 par value0.00.0007/30/2026 Filed 2026-07-31SCHEDULE 13G/AAmendment 1Open filing 0001214659-26-009273 Dispute this row
BAIRD TRUST Co Common Stock0.021,075.0003/31/2026 Filed 2026-04-14SCHEDULE 13G/AAmendment 1Open filing 0001442181-26-000008 Dispute this row
BAIRD FINANCIAL CORP Common Stock0.021,075.0003/31/2026 Filed 2026-04-14SCHEDULE 13G/AAmendment 1Open filing 0001442181-26-000008 Dispute this row
Baird Financial Group, Inc. Common Stock0.021,075.0003/31/2026 Filed 2026-04-14SCHEDULE 13G/AAmendment 1Open filing 0001442181-26-000008 Dispute this row
BAIRD TRUST Co Common Stock8.5760,293.0012/31/2025 Filed 2026-02-06SCHEDULE 13GOpen filing 0001442181-26-000002 Dispute this row
BAIRD FINANCIAL CORP Common Stock8.5760,293.0012/31/2025 Filed 2026-02-06SCHEDULE 13GOpen filing 0001442181-26-000002 Dispute this row
Baird Financial Group, Inc. Common Stock8.5760,293.0012/31/2025 Filed 2026-02-06SCHEDULE 13GOpen filing 0001442181-26-000002 Dispute this row

Percent is of the class the filing names, as the holder stated it. Members of a group each report the group’s shares, so rows are not added together.

What was read

2,429,628 filings read, dated 2004-06-14 to 2026-11-17: Forms 3, 3/A, 4, 4/A, 5, 5/A.

Years can be incomplete while the archive is still being read. A year with few filings here is not a statement that few were made.

Filings read, by filing year
Filing yearFilings read
201517,836
2016222,374
2017207,870
2018222,268
2019215,153
2020166,955
2021249,834
2022187,707
2023205,922
2024209,823
2025235,520
2026260,174

Filings made before the SEC required XML are listed, not extracted.

Back to SANARA MEDTECH INC.